Efficacy and safety of endoscopic retrograde cholangiopancreatography combined with oral cholangiopancreatography in the treatment of duodenal papilla cholecystectomy
Journal Title: Journal of Clinical Hepatology - Year 2025, Vol 41, Issue 3
Abstract
[Objective] To investigate the feasibility and safety of endoscopic retrograde cholangiopancreatography (ERCP) combined with oral cholangiopancreatography in the treatment of major duodenal papilla gallbladder polyps. [Methods] A retrospective analysis was performed for the clinical data of eight patients with choledocholithiasis and gallbladder polyps who underwent ERCP and combined with oral cholangiopancreatography for major duodenal papilla cholecystectomy in Center of Digestive Endoscopy, Jilin People’s Hospital, from May 2022 to June 2024, and related data were collected, including the success rate of surgery, the technical success rate of gallbladder polyp removal, the superselective method of cystic duct, the time of operation, the time of gallbladder polyp removal, and surgical complications. [Results] Both the success rate of surgery and the technical success rate of gallbladder polyp removal reached 100%, and of all eight patients, three patients used guide wire to enter the gallbladder under direct view, while five patients received oral cholangiopancreatography to directly enter the gallbladder. The time of operation was 51.88±12.34 minutes, and the time of gallbladder polyp removal was 23.13±10.94 minutes. The diameter of gallbladder polyp was 2 — 8 mm, and pathological examination showed inflammatory polyps in three patients, adenomatous polyps in one patient, and cholesterol polyps in four patients. There were no complications during or after surgery. The patients were followed up for 2 — 27 months after surgery, and no recurrence of gallbladder polyp was observed. [Conclusion] Oral cholangiopancreatography is technically safe and feasible in endoscopic major duodenal papilla cholecystectomy.
Authors and Affiliations
Liying TAO, Hongguang WANG, Qingmei GUO, Xiang GUO, Lianyu PIAO, Muyu YANG, Yong YU, Libin RUAN, Jianbin GU, Si CHEN, Yingting DU, Xiuying GAI, Sijie GUO
Toward zero mother-to-child transmission of hepatitis B virus: From controversy to consensus
Mother-to-child transmission is the major route of transmission for hepatitis B virus (HBV), and prevention of the mother-to-child transmission of HBV is the key link in the prevention and control of hepatitis B and o...
The role of endoplasmic reticulum stress in non-alcoholic fatty liver disease and related targeted therapies
Non-alcoholic fatty liver disease (NAFLD) is a series of diseases characterized by hepatic steatosis and is also a metabolism-associated disease and an important factor for liver fibrosis, liver cirrhosis, and hepato...
Liver involvement in pediatric rheumatic diseases
Pediatric rheumatic diseases are a group of complex chronic inflammatory disorders, mainly including juvenile idiopathic arthritis, diffuse connective tissue diseases, systemic vasculitis, and autoinflammatory diseas...
Influence of metabolism-related factors on the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure and establishment of a predictive model
[Objective] To investigate the influence of metabolism-related factors (overweight and/or obesity, hyperglycemia, hypertension and dyslipidemia)on the 90-day prognosis of patients with hepatitis B virus-related acute...
Association of the adipokine Chemerin with the development and progression of liver fibrosis
Liver fibrosis is the common pathological process in the progression of various chronic liver diseases to liver cirrhosis, and it greatly affects the prognosis of patients with chronic liver diseases. As a novel adipoki...